Global pharmaceutical giant Takeda is adjusting its Boston-area real estate portfolio by offloading space in some properties as it prepares to expand in others.
Global pharmaceutical giant Takeda is adjusting its Boston-area real estate portfolio by offloading space in some properties as it prepares to expand in others.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
585 Kendall St, Cambridge, MA
Manufacturing